Tuesday, November 5, 2024
HomeTagsIAP Antagonist APG-1387

IAP Antagonist APG-1387

AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that it has...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics